beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

By Valerie M. Weaver, S. Lelièvre, J. Lakins, M. Chrenek, Jonathan C. R. Jones, F. Giancotti, Zena Werb, Mina J. Bissell. Cancer Cell, 2002

851 citations recorded by the source corpus.

Tumor cells can evade chemotherapy by acquiring resistance to apoptosis. We investigated the molecular mechanism whereby malignant and nonmalignant mammary epithelial cells become insensitive to apoptosis. We show that regardless of growth status, formation of polarized, three-dimensional structures driven by basement membrane confers protection to apoptosis in both nonmalignant and malignant mammary epithelial cells. By contrast, irrespective of their malignant status, nonpolarized structures are sensitive to induction of apoptosis. Resistance to apoptosis requires ligation of beta4 integrins, which regulates tissue polarity, hemidesmosome formation, and NFkappaB activation. Expression of beta4 integrin that lacks the hemidesmosome targeting domain interferes with tissue polarity and NFkappaB activation and permits apoptosis. These results indicate that integrin-induced polarity may drive tumor cell resistance to apoptosis-inducing agents via effects on NFkappaB.

Subfields: Immunology, Immunology and Allergy, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/b76310349e00ca767020a02492682ebd06fa802c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

In Immunology and Allergy

In Molecular Biology

Citations in the corpus

Balancing forces: architectural control of mechanotransduction (2011, neutral): “Conversely, MECs grown in 2D monolayers are exquisitely sensitive to cell death induced by these stimul”
Modelling glandular epithelial cancers in three-dimensional cultures (2005, background): “By contrast, non-polarized cells are uniformly sensitive to apoptosi”
2D and 3D cell cultures – a comparison of different types of cancer cell cultures (2016, background): “Due to disturbances in interactions with the external environment, cells growing adherently lose their polarity [20], which changes the response of those cells to various phenomena, such as to apoptosis [21, 22].”
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers (2020, background): “Up to 5% of patients admitted at major cancer centers are diagnosed with ‘‘cancer of unknown primary origin,’’ and their treatment consists of a combination of several highly cytotoxic therapies (Stella et al., 2012; Varadhachary and Raber, 2014).”
Tensegrity II. How structural networks influence cellular information processing networks (2003, background): “…structure (Mochitate et al., 1991) and focal adhesion formation (Balaban et al., 2001), as well as cell growth, differentiation, motility and apoptosis in response to chemotherapeutic agents (Li et al., 1987; Ben Ze’ev et al., 1988; Opas, 1989; Mochitate et al., 1991; Weaver et al., 2002).”
The organizing principle: microenvironmental influences in the normal and malignant breast. (2002, methodology): “Specifically, we found that resistance to apoptosis strictly correlated with ECM-induced polarity in 3D (Fig. 8; Weaver et al., 2002).”
Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. (2010, background): “In fact, early multicellular models described influences of cancer microregions on the responsiveness to cytotoxic agents [11,16].”
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research (2008, neutral): “[33] and Debnath et al.”
Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues (2012, background): “For instance, apical-basal polarity has been shown to modulate the sensitivity of cells to apoptosis (Weaver et al., 2002).”
Nanomedicine therapeutic approaches to overcome cancer drug resistance (2013, background): “Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V. NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells.”